Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
A well-designed RCT in an understudied population showing feasibility and safety of exercise during chemotherapy, with secondary benefits in strength preservation and toxicity reduction, though the primary fatigue endpoint was not met.
A scoping review mapping the landscape of non-pharmacological interventions without quality assessment, effect synthesis, or meta-analysis; descriptive and gap-identifying rather than outcome-determining.
Early-stage preclinical and animal study demonstrating analgesic efficacy of thymoquinone in paclitaxel-induced neuropathy, but with limited structural neuroprotection and no human data, requiring confirmation before clinical translation.
Systematic review and meta-analysis of 197 studies with 72,794 patients providing a pooled prevalence estimate with confidence interval; rigorous methodology but epidemiological rather than intervention-based evidence.
Large, well-designed longitudinal cohort study with up to 18 years of follow-up, prespecified statistical correction, and consistent associations across cognitive and neuroimaging endpoints, though observational design and potential confounding limit practice-changing claims.
A well-designed prospective cohort study with 24-month follow-up and multivariate analysis identifies modifiable psychological mediators of post-treatment fatigue in breast cancer survivors, with clear effect sizes and controlled comparators.
Qualitative descriptive study with small sample (n=16) exploring experiences and needs; generates contextual understanding but lacks quantitative measurement, control group, or hypothesis testing.
A two-case uncontrolled report of a single intervention session with no comparator, using a mix of validated scales and qualitative analysis, too limited in scope and design to establish efficacy.